Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page no longer lists the condition Head and neck squamous cell carcinoma and removes related topics such as MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-01-06T03:21:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added related topic links: Head and neck squamous cell carcinoma and MedlinePlus Genetics; no changes to the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-30T02:28:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Locations section added with a comprehensive list of sites (Arizona, California, Colorado, Connecticut, Florida, Illinois, Kansas, Louisiana, Maryland, Michigan, Minnesota, New York, Oregon, Pennsylvania, South Carolina, Texas, Virginia, Ontario). The update replaces the previous per-location headings and removes the HHS Vulnerability Disclosure link.
    Difference
    2%
    Check dated 2025-12-23T00:46:58.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Removed the primary disease term 'Head and neck squamous cell carcinoma' and the related topic 'MedlinePlus Genetics' from the page, while updating the revision note from v3.3.1 to v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-01T12:46:58.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added related topics including Head and neck squamous cell carcinoma and MedlinePlus Genetics, and updated the PubMed publication note by removing older phrasing.
    Difference
    0.2%
    Check dated 2025-11-24T12:21:19.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page removed the government operating status notice and deleted the 'Head and neck squamous cell carcinoma' topic and the 'MedlinePlus Genetics' related topics section.
    Difference
    0.5%
    Check dated 2025-11-17T06:23:20.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.